ILMN vs INTS
Illumina Inc (ILMN) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
INTS does not have a complete income-statement cache yet.
ILMN currently screens at market cap $15.84B. INTS currently screens at market cap $7.7M.
Not investment advice. Open the ILMN and INTS stock pages for the full models.
Not investment advice.